Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide) [Phase 4]

View source ↗

Summary

Phase 4 PK/PD study of Glufast tablets 10mg (mitiglinide) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glufast tablets 10mg (mitiglinide)

Snippet

Sponsor: Orient Europharma Co., Ltd. | Conditions: Type 2 Diabetes Mellitus, Liver Dysfunction | Phase 4 | Status: COMPLETED